Highlights AtriCure, Inc.

Equities

ATRC

US04963C2098

Real-time Estimate Cboe BZX Other stock markets 01:48:23 2024-04-29 pm EDT			5-day change	1st Jan Change
23.56 ^USD	+1.68%		+4.14%	-33.73%

Apr. 23	Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32	MT
Apr. 18	AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management	Apr. 18	CI
AtriCure Q4 Loss Widens, Revenue Rises; 2024 Guidance Set	Feb. 15	MT
Earnings Flash (ATRC) ATRICURE Reports Q4 Revenue $106.5M, vs. Street Est of $104.2M	Feb. 15	MT
Atricure, Inc. Provides Earnings Guidance for 2024	Feb. 15	CI
AtriCure, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 15	CI
AtriCure Reports Higher Preliminary Q4, 2023 Revenue; Issues 2024 Revenue Guidance; Shares Rise	Jan. 08	MT
Atricure, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Provides Financial Guidance for the Year 2024	Jan. 08	CI
AtriCure's Q3 Adjusted Loss Narrows, Revenue Rises; Full-Year Guidance Adjusted	Nov. 01	MT
Earnings Flash (ATRC) ATRICURE Posts Q3 Revenue $98.3M, vs. Street Est of $96.6M	Nov. 01	MT
AtriCure, Inc. Provides Revenue Guidance for the 2023	Nov. 01	CI
AtriCure, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01	CI
AtriCure Q2 Non-GAAP Loss Narrows as Sales Increase	23-07-25	MT
Earnings Flash (ATRC) ATRICURE Reports Q2 Revenue $100.9M, vs. Street Est of $97.5M	23-07-25	MT
Atricure, Inc. Provides Revenue Guidance for the Year 2023	23-07-25	CI
AtriCure, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-25	CI
AtriCure Q1 Adjusted Loss Narrows, Revenue Increases	23-05-03	MT
Earnings Flash (ATRC) ATRICURE Posts Q1 Revenue $93.5M, vs. Street Est of $87.5M	23-05-02	MT
Atricure, Inc. Provides Revenue Guidance for Full Year 2023	23-05-02	CI
AtriCure, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-02	CI
AtriCure's Q4 Adjusted Loss Narrows, Revenue Rises; Issues 2023 Guidance	23-02-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights AtriCure, Inc.

Equities

ATRC

US04963C2098

Highlights

Filters